gastric and gastroesophageal junction (GEJ) adenocarcinomaHER2-amplified colorectal cancerHER2-low breast cancerHER2-positive breast cancerLeica BiosystemsIndica Labsimmune checkpoint blockadeHER2-targeted therapy
…se important biomarkers and the neighboring microenvironment.In gastric and gastroesophageal junction (GEJ) adenocarcinoma, HER2+/PD-L1+ tumors exhibited distinct immune profiles, with s…